Abstract
Prenatal maternal smoking is associated with low birthweight, neurological disorders, and asthma in exposed children. DNA methylation signatures can function as biomarkers of prenatal smoke exposure. However, the robustness of these DNA methylation signatures across child ages, genetic ancestry groups, or tissues is not clear. Using coefficients from a meta-analysis of prenatal maternal smoke exposure and DNA methylation in newborn cord blood, we created polymethylation scores of saliva DNA methylation from children at ages 9 and 15 in the Fragile Families and Child Wellbeing study. In the full sample at age 9 (n=753), prenatal maternal smoke exposure was associated with a 0.51 (95%CI: 0.35, 0.66) standard deviation higher polymethylation score. The direction and magnitude of the association was consistent in European and African genetic ancestry samples. In the full sample at age 15 (n=747), prenatal maternal smoke exposure was associated with a 0.48 (95%CI: 0.32, 0.63) standard deviation higher polymethylation score, and the association was attenuated among the European and Admixed - Latin genetic ancestry samples. The polymethylation score classified prenatal maternal smoke exposure accurately (AUC age 9=0.77, age 15=0.76). Including the polymethylation score increased the AUC of base model covariates by 5 (95% CI: (2.1, 7.2)) percentage points, while including a single candidate site in the AHRR gene did not (P-value=0.19). Polymethylation scores for prenatal maternal smoking were portable across genetic ancestries and more accurate than an individual DNA methylation site. DNA polymethylation scores from saliva samples could serve as robust and practical clinical biomarkers of prenatal maternal smoke exposure.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was made possible through several grants (Fragile Families Core Data Collection: R01 HD036916, genetic data processing R01 HD36916, R01 HD073352, R01 MD011716, and R01 HD076592). FB was supported by F31 DE029992 and R25 AG053227. KB was supported by R01 AG074887 and R01 MD013299. EB was supported by R01 AG055406, R01 AG067592, and R01 MD011716. LS, DN, and JF were supported by R01 HD076592, R01 MD011716. CM was supported by R01 AG07107, R01 MD011716, R01 HD076592.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Institutional Review Board of the University of Michigan gave ethical approval for this work (IRB, HUM00129826).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵* Co-senior authors
Typo corrected in author names, typo corrected in polymethylation score descriptor, new supplemental table detailing CpG inclusion in scores, minor text revisions
Data Availability
Code to perform all analyses is available (www.github.com/bakulskilab). Survey data for the Fragile Families and Child Wellbeing study are publicly available (https://fragilefamilies.princeton.edu/documentation). DNA methylation and genetic data in the Fragile Families and Child Wellbeing study are available through the Restricted Use Contract (https://fragilefamilies.princeton.edu/restricted), upon demonstrated Institutional Review Board approval of the proposed research and data protection plan.